Dabrafenib plus Trametinib: A breakthrough in pediatric low‐grade glioma therapy
Abstract Background and Aims Pediatric‐type low‐grade gliomas (pLGGs) are the most common solid tumors in children, with v‐raf murine sarcoma viral oncogene homolog B (BRAF) mutations playing a significant role in their development. Dabrafenib and trametinib are targeted therapies that are recently...
Shranjeno v:
| Principais autores: | , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Wiley
2024-01-01
|
| Serija: | Health Science Reports |
| Teme: | |
| Online dostop: | https://doi.org/10.1002/hsr2.1841 |
| Oznake: |
Brez oznak, prvi označite!
|